tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DYN Stock Latest News

Dyne Therapeutics price target lowered to $41 from $46 at Evercore ISI
The FlyDyne Therapeutics price target lowered to $41 from $46 at Evercore ISI
3d ago
DYN
Dyne Therapeutics’ DYNE-251 Study Update: A Potential Game-Changer for Duchenne Muscular Dystrophy
PremiumCompany Announcements
Dyne Therapeutics’ DYNE-251 Study Update: A Potential Game-Changer for Duchenne Muscular Dystrophy
4d ago
DYN
Dyne Therapeutics Announces $200M Public Offering
PremiumCompany Announcements
Dyne Therapeutics Announces $200M Public Offering
13d ago
8K
DYN
Morning Movers: Tesla dips as Musk and Trump resume feud
PremiumThe Fly
Morning Movers: Tesla dips as Musk and Trump resume feud
13d ago
SG
DYN
Dyne Therapeutics 24.2M share Spot Secondary priced at $8.25
PremiumThe Fly
Dyne Therapeutics 24.2M share Spot Secondary priced at $8.25
13d ago
DYN
Closing Bell Movers: Progress Software slips 4% after earnings
PremiumThe FlyClosing Bell Movers: Progress Software slips 4% after earnings
14d ago
CXW
DYN
Dyne Therapeutics Secures $275M Loan Agreement
Premium
Company Announcements
Dyne Therapeutics Secures $275M Loan Agreement
14d ago
8K
DYN
Dyne Therapeutics files $200M common stock offering
Premium
The Fly
Dyne Therapeutics files $200M common stock offering
14d ago
DYN
Dyne Therapeutics initiated with a Buy at JonesResearch
PremiumThe Fly
Dyne Therapeutics initiated with a Buy at JonesResearch
19d ago
DYN
Dyne Therapeutics initiated with a Market Perform at Bernstein
PremiumThe Fly
Dyne Therapeutics initiated with a Market Perform at Bernstein
20d ago
DYN
Dyne Therapeutics initiated with a Market Perform at Bernstein
PremiumThe Fly
Dyne Therapeutics initiated with a Market Perform at Bernstein
20d ago
DYN
Dyne Therapeutics price target lowered to $32 from $46 at Baird
PremiumThe Fly
Dyne Therapeutics price target lowered to $32 from $46 at Baird
26d ago
DYN
Dyne Therapeutics: Strategic Advancements and Promising Clinical Data Drive Buy Rating
PremiumRatingsDyne Therapeutics: Strategic Advancements and Promising Clinical Data Drive Buy Rating
26d ago
DYN
Dyne Therapeutics’ DYNE-101 Gains Momentum with FDA Breakthrough Designation and Optimized Clinical Trials
Premium
Ratings
Dyne Therapeutics’ DYNE-101 Gains Momentum with FDA Breakthrough Designation and Optimized Clinical Trials
26d ago
DYN
Dyne having vHOT as primary endpoint ‘encouraging,’ says H.C. Wainwright
Premium
The Fly
Dyne having vHOT as primary endpoint ‘encouraging,’ says H.C. Wainwright
27d ago
DYN
Positive Outlook for Dyne Therapeutics: Buy Rating Justified by Promising DYNE-101 Trial Results and Strategic Moves
PremiumRatings
Positive Outlook for Dyne Therapeutics: Buy Rating Justified by Promising DYNE-101 Trial Results and Strategic Moves
27d ago
DYN
Dyne at ‘attractive entry point’ following pullback, says Chardan
PremiumThe Fly
Dyne at ‘attractive entry point’ following pullback, says Chardan
27d ago
DYN
Morning Movers: Verve skyrockets after deal to be acquired by Eli Lilly
PremiumThe Fly
Morning Movers: Verve skyrockets after deal to be acquired by Eli Lilly
27d ago
DYN
JBL
Dyne Therapeutics: Strategic Shift to vHOT and FDA Support Bolster Buy Rating
PremiumRatings
Dyne Therapeutics: Strategic Shift to vHOT and FDA Support Bolster Buy Rating
27d ago
DYN
Dyne Therapeutics pivot on primary endpoint will ‘raise questions,’ says Stifel
PremiumThe FlyDyne Therapeutics pivot on primary endpoint will ‘raise questions,’ says Stifel
27d ago
DYN
Dyne Therapeutics sinks 20% after changing study endpoint
Premium
The Fly
Dyne Therapeutics sinks 20% after changing study endpoint
27d ago
DYN
Dyne Therapeutics Granted Breakthrough Therapy Designation
Premium
Company Announcements
Dyne Therapeutics Granted Breakthrough Therapy Designation
27d ago
8K
DYN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >